Canadian Prime Minister Justin Trudeau toured a Pfizer manufacturing facility in Puurs, Belgium alongside Belgian Prime Minister Alexander De Croo on Tuesday. It was Trudeau’s last day of his first international trip in more than a year, where he visited the plant that played a pivotal role in Canada’s early rollout of the COVID-19 vaccine.
The facility produced Canada’s supply of the Pfizer-BioNTech vaccine until the United States started shipping doses early last month.
Canada faced some bumps in its vaccination campaign earlier this year when a slowdown at the production plant in Belgium disrupted delivery plans.
This week alone, Canada is set to receive 2.4 million doses of the vaccine from Pfizer-BioNTech, which has been consistently delivering large weekly shipments since mid-March.
For more info, please go to https://globalnews.ca/news/7950456/trudeau-covid-pfizer-quarantine/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #Pfizer #COVID
The facility produced Canada’s supply of the Pfizer-BioNTech vaccine until the United States started shipping doses early last month.
Canada faced some bumps in its vaccination campaign earlier this year when a slowdown at the production plant in Belgium disrupted delivery plans.
This week alone, Canada is set to receive 2.4 million doses of the vaccine from Pfizer-BioNTech, which has been consistently delivering large weekly shipments since mid-March.
For more info, please go to https://globalnews.ca/news/7950456/trudeau-covid-pfizer-quarantine/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #Pfizer #COVID
- Category
- U.S. & Canada
- Tags
- global news, COVID-19, corona virus
Sign in or sign up to post comments.
Be the first to comment